CRISPR Insider™

CRISPR News and Information from Around The World

New CRISPR method efficiently corrects Duchenne muscular dystrophy defect in heart tissue

Posted by btwatson on February 7, 2018 8:26 am
Tags:
Categories: Uncategorized

Source: New CRISPR method efficiently corrects Duchenne muscular dystrophy defect in heart tissue

[unable to retrieve full-text content]

  1. New CRISPR method efficiently corrects Duchenne muscular dystrophy defect in heart tissue  Science Daily
  2. New CRISPR method efficiently corrects DMD defect in heart tissue  Phys.Org
  3. Two Types of CRISPR Gene Editing Could Be Useful in Treating Sickle Cell Anemia, Editas Reports  Sickle Cell Anemia News
  4. Full coverage

Published at Tue, 06 Feb 2018 19:57:56 +0000

Leave a Reply Cancel reply

You must be logged in to post a comment.

< CRISPR Insider™ home

Crispr News

  • Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market Report 2022: Industry Insights, Size, Growth, Demand and Forecast by 2028 – Designer Women - Designer Women
    June 29, 2022
  • Different Takes: Mark Cuban Is Shaking Up The Drug Industry; CRISPR Still Has Some Bugs To Work Out - Kaiser Health News
    June 29, 2022
  • Eligo unlocks next generation of precision genetic medicine with foundational patents granted covering in-situ base editing of the microbiome and presents first-ever animal data at CRISPR 2022 Conference - PR Newswire
    June 29, 2022
  • Global Cell Theraputics Market to Generate High Revenue 2022-2029 | Crispr Therapeutics, Roche (Spark Therapeutics), PTC Therapeutics – Designer Women - Designer Women
    June 29, 2022
  • 3 Revolutionary Stocks I'd Buy Right Now Without Hesitation - The Motley Fool
    June 29, 2022
  • What's next for the gene-edited children from CRISPR trial in China? - New Scientist
    June 29, 2022
  • Short Regularly Spaced Palindromic Repeat (CRISPR) Gene Editing Market Size, Share, Growth, Analysis Forecast to 2028 – Designer Women - Designer Women
    June 29, 2022
  • Corrections: June 29, 2022 - The New York Times
    June 29, 2022
  • Gene Editing Tools Market Share by Application: 2022-2030| Thermofisher Scientific, CRISPR Therapeutics, Editas Medicine – Designer Women - Designer Women
    June 29, 2022
  • Do agri-businesses 'control' agriculture? The emerging gene-editing revolution in Latin America is challenging that belief - Genetic Literacy Project
    June 29, 2022
  • Community Engagement Software Market Quality & Quantity Analysis | Beam Therapeutics, CRISPR Therapeutics, GenScript – Indian Defence News - Indian Defence News
    June 29, 2022
  • Your Wednesday Briefing - The New York Times
    June 29, 2022
  • A Comprehensive Guide to Genomic ETFs - Yahoo Finance
    June 28, 2022
  • ERS Genomics Licenses CRISPR Tech to Swiss Firm Cytosurge - GenomeWeb
    June 28, 2022
  • Gut bacteria go on record - Nature.com
    June 28, 2022
  • CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
    CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
  • CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
  • The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
    The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
  • The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
  • ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
    ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
  • The Dark Side of CRISPR – Scientific American
    The Dark Side of CRISPR – Scientific American
  • ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
    ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
  • Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
    Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
  • DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
    DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
  • CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
    CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
  • Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
    Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
  • Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
    Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
  • Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
    Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
  • New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
    New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
  • After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
    After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
  • Load more [+]

Copyright 2020 CrisprInsider.com